![[dr. bob]](/dr-bob-sm.gif)
Dr. Bob is Robert Hsiung, MD,
bob@dr-bob.orgShown: posts 1 to 3 of 3. This is the beginning of the thread.
Posted by River1924 on February 6, 2007, at 23:50:32
* Atomoxetine therapy should not be used in patients with structural cardiac abnormalities or other serious heart conditions because of the potential increased vulnerability to its noradrenergic effects, leading to sudden death and other serious cardiovascular events. Use of atomoxetine at normal doses has also been linked to treatment-emergent psychotic/manic symptoms in pediatric patients with no prior history of such events.
Posted by Phillipa on February 7, 2007, at 11:48:56
In reply to FYI FDA changes labeling Stratterra, posted by River1924 on February 6, 2007, at 23:50:32
Only pediatric patients? As someone I know is more depressed on straterra . Thanks Phillipa
Posted by River1924 on February 7, 2007, at 13:15:05
In reply to FYI FDA changes labeling Stratterra, posted by River1924 on February 6, 2007, at 23:50:32
Well, this an addition to the current labeling which includes about every adverse effect under the sun... just from my own brief time on it, I think it would have made me anxiously restless and irritable as well as sleepy....
This is the end of the thread.
Psycho-Babble Medication | Extras | FAQ
Dr. Bob is Robert Hsiung, MD,
bob@dr-bob.org
Script revised: February 4, 2008
URL: http://www.dr-bob.org/cgi-bin/pb/mget.pl
Copyright 2006-17 Robert Hsiung.
Owned and operated by Dr. Bob LLC and not the University of Chicago.